Home » Stocks » EPIX

ESSA Pharma Inc. (EPIX)

Stock Price: $6.55 USD 0.06 (0.92%)
Updated November 27, 1:00 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 136.52M
Revenue (ttm) n/a
Net Income (ttm) -10.44M
Shares Out 20.84M
EPS (ttm) -1.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 27
Last Price $6.55
Previous Close $6.49
Change ($) 0.06
Change (%) 0.92%
Day's Open 6.50
Day's Range 6.36 - 6.73
Day's Volume 41,650
52-Week Range 3.00 - 8.31

More Stats

Market Cap 136.52M
Enterprise Value 86.64M
Earnings Date (est) Dec 9, 2020
Ex-Dividend Date n/a
Shares Outstanding 20.84M
Float 14.18M
EPS (basic) -1.24
EPS (diluted) -1.03
FCF / Share -1.45
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 12,645
Short Ratio 0.08
Short % of Float 0.09%
Beta 1.68
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 5.10
Revenue n/a
Operating Income -12.17M
Net Income -10.44M
Free Cash Flow -12.25M
Net Cash 49.89M
Net Cash / Share 2.39
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -61.60%
ROE -106.04%
ROIC -729.90%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (3)

Buy 3
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(83.21% upside)
Current: $6.55
Target: 12.00
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-12.17-10.80-10.87-18.70-10.23-1.74
Net Income-10.44-11.63-4.50-13.14-9.68-1.82
Shares Outstanding8.434.571.451.350.920.78
Earnings Per Share-1.24-2.55-3.09-9.77-10.60-2.40
Operating Cash Flow-12.25-10.22-17.35-15.30-13.34-2.08
Capital Expenditures----0.01-0.17-
Free Cash Flow-12.25-10.22-17.35-15.31-13.51-2.08
Cash & Equivalents53.6015.033.968.991.583.70
Total Debt3.716.327.96---
Net Cash / Debt49.898.71-4.008.991.583.70
Book Value49.189.15-4.27-0.544.461.97
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name ESSA Pharma Inc.
Country Canada
CEO David R. Parkinson

Stock Information

Ticker Symbol EPIX
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: EPIX


ESSA Pharma engages in the development of small molecule drugs for prostate cancer. It focuses on producing drugs which selectively block the amino-terminal domain (NTD) of the androgen receptor (AR), potentially overcoming the known AR-dependent resistance mechanisms of castration-resistant prostate cancer (CRPC), and providing CRPC patients with the potential for increased progression-free and overall survival. The company was founded by Marianne D. Sadar and Raymond J. Andersen on January 6, 2009 and is headquartered in Vancouver, Canada.